Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial.

Overview
Research
Identity
Additional Document Info
View All

authors

Ismaeel Yunusa, PharmD, PhD

publication date

2024

published in

Journal of Alzheimer's disease : JAD Journal

has subject area